Healthcare & Medical Devices Global On demand · 24-48h

Global Blood Sugar Monitoring Equipment Market Strategic Research Report

Global Blood Sugar Monitoring Equipment Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Sugar Monitoring Equipment Market
$15.13B2025
4.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Intrusive, Non-Invasive

By Application: Hospital Use, Home Use

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Abbott, DexCom, Cnoga Medical, Medtronic, Senseonics Holdings, Glucotrack, Inc., I-SENS, Roche, Ascensia, ARKRAY, OMRON, B. Braun Medical, AgaMatrix, ALL Medicus, Terumo Corporation, Sinocare, Huzhou Meiqi Medical Instruments, Zhejiang POCTech Corporation, MicroTech Medical, SIBIONICS, Bobang Fangzhou Medical Technology, Medtrum Technologies

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 147 pages
Market size 2025
$15.13B
Billion USD
Forecast CAGR
4.7%
2025-2032
Forecast 2032
$20.9B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Blood Sugar Monitoring Equipment market size is predicted to grow from US$ 15,127 million in 2025 to US$ 20,718 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

The blood sugar monitoring equipment is a medical device used to detect and track the glucose level of human blood or interstitial fluid, which mainly serves the daily self-management of diabetes patients, hospital blood glucose monitoring, pregnancy blood glucose management, intensive care, chronic disease follow-up, health management and other scenarios. The product form includes finger tip glucose meter, blood glucose test paper, blood sampling pen, blood sampling needle, continuous blood glucose monitoring system, flash blood glucose monitoring system, sensors, transmitters, receivers and supporting mobile phone application modules. Traditional fingertip blood glucose monitoring devices collect capillary blood and use enzyme electrode electrochemical reactions to measure blood glucose levels, while continuous blood glucose monitoring devices continuously detect changes in interstitial fluid glucose through subcutaneous sensors, forming trend curves, alarm prompts, and data management reports. In 2025, global Blood Sugar Monitoring Equipment production reached approximately 94.87 M Units, with an average global market price of around US$ 163 per unit.

The blood sugar monitoring equipment market is upgrading from a single point detection tool to a continuous, intelligent and data service. The traditional fingertip blood glucose meter and test paper are still the products with the largest basic demand, but the continuous blood glucose monitoring equipment is growing faster, and is becoming an important entrance to high-end diabetes management. Diabetes patients' attention to blood glucose fluctuations, postprandial blood glucose, nighttime hypoglycemia and blood glucose changes during exercise has continued to increase. A single test has been difficult to meet the needs of refined management, and products that can provide trend charts, alarm alerts, cloud records and doctors' remote viewing functions are more easily recognized by users. Future industry opportunities will focus on continuous glucose monitoring sensors, low-cost household monitoring equipment, smart phone connected glucose meters, hospital bedside detection systems, chronic disease data management platforms and diabetes closed-loop management solutions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Sugar Monitoring Equipment market?

What factors are driving Blood Sugar Monitoring Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Sugar Monitoring Equipment market opportunities vary by end market size?

How does Blood Sugar Monitoring Equipment break out by Type, by Application?

This report presents a comprehensive overview of the global Blood Sugar Monitoring Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Intrusive
  • Non-Invasive

Segment by Measurement Range

  • CGM(2.0 mmol/L-25.0 mmol/L)
  • SMBG(0.6 mmol/L-33.3 mmol/L)

Segment by Users

  • Adult Blood Glucose Meter
  • Children'S Blood Glucose Meter

Segment by Application

  • Hospital Use
  • Home Use

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Sugar Monitoring Equipment market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital Use, Home Use evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blood Sugar Monitoring Equipment Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$15.13B
2025
Forecast
$20.9B
2032
CAGR
4.7%
2025–2032
Regionen
5
global
Key companies
AbbottDexComCnoga MedicalMedtronicSenseonics HoldingsGlucotrack, Inc.I-SENSRoche
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
IntrusiveNon-Invasive
By Application
Hospital UseHome Use

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Intrusive
  • 3.1.3 Non-Invasive
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital Use
  • 4.1.3 Home Use
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Abbott
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 DexCom
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cnoga Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medtronic
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Senseonics Holdings
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Glucotrack, Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 I-SENS
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Roche
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ascensia
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ARKRAY
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 OMRON
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 B. Braun Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 AgaMatrix
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 ALL Medicus
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Terumo Corporation
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Sinocare
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Huzhou Meiqi Medical Instruments
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Zhejiang POCTech Corporation
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 MicroTech Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 SIBIONICS
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Bobang Fangzhou Medical Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Medtrum Technologies
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Blood Sugar Monitoring Equipment market?
The global Blood Sugar Monitoring Equipment market is estimated at US$ 15.13 billion in 2025 (base year) and is projected to reach US$ 20.72 billion by 2032.
What is the forecast CAGR for the Blood Sugar Monitoring Equipment market?
The market is expected to grow at a CAGR of 4.7% from 2026 to 2032, expanding from US$ 15.13 billion in 2025 to US$ 20.72 billion in 2032, roughly 1.4 times its base-year value.
What is Blood Sugar Monitoring Equipment?
The blood sugar monitoring equipment is a medical device used to detect and track the glucose level of human blood or interstitial fluid, which mainly serves the daily self-management of diabetes patients, hospital blood glucose monitoring, pregnancy blood glucose management, intensive care, chronic disease follow-up, health management and other scenarios.
What are the main segments of the Blood Sugar Monitoring Equipment market by type?
By type, the market is segmented into Intrusive and Non-Invasive.
Which applications drive demand in the Blood Sugar Monitoring Equipment market?
Key applications covered include Hospital Use and Home Use.
Who are the key players in the Blood Sugar Monitoring Equipment market?
Key players profiled include Abbott, DexCom, Cnoga Medical, Medtronic, Senseonics Holdings, Glucotrack, I-SENS and Roche, among 22 companies covered in total.
Which regions and countries are covered for Blood Sugar Monitoring Equipment?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Blood Sugar Monitoring Equipment market?
What factors are driving Blood Sugar Monitoring Equipment market growth, globally and by region?
Who should buy the Blood Sugar Monitoring Equipment market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital Use and Home Use, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Sugar Monitoring Equipment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.